Telitacicept
RemeGen
['telitacicept']
phase ii trial of telitacicept for
sjorgrens #eular2023 essdai score in both 160mg and 240mg groups at 12 weeks, unclear at 24 weeks. results for salivary flow and dry eye were not statistically significant...small sample size? 
MPT/PhD Student @UBC @Arthritis_ARC | Programs Coordinator @ACEJointHealth | Person living with inflammatory arthritis | Movement enthusiast